Here's an M-App Connected With a Futuristic Virtual Healthcare Platform And Digital Therapeutics In Asia
Epillo's operations are available in India, South Asia, and UAE, though you can get it on your device anywhere in the world
Europe-based
digital health startup Epillo
has launched a unique integrated mobile application for patients, connected
with a digital health delivery system for healthcare practitioners, and care
providers. This interconnected technology is here to transform the quality of
virtual care for patients while increasing the reach for patients, and
healthcare providers (doctors, care teams, clinic managers, pharmacies,
laboratories, health coaches, dieticians).
While COVID-19
has accelerated the shift towards digital health, the tech companies have
driven fresh optimism, and could bring a turning point for the burdened
healthcare industry, while increasing access to quality care and optimizing
patient health outcomes.
The Epillo mobile app is
available on iOS and Android Play stores in Asia and UAE.
Epillo’s
e-medical records service intuitively organizes patient visits, helps providers
document faster and more accurately, and sets a doctor’s practice up for future
success: whether you’re a small practice or a large healthcare system. The
interconnected solution line has systems for doctors, care-teams, clinic
managers, pharmacies, laboratories, health coaches, dieticians to virtually
interact with patients through features like symptom checker, health assessment,
teleconsultation, virtual care delivery, and patient monitoring.
As the digital
revolution converges with healthcare into the exciting new field of digital
health, individuals and care providers are easily able to track, manage and
improve health outcomes. Digital health is helping to reduce inefficiencies in
delivery of care by making healthcare more connected while at the same time it
is streamlining access, improving quality and making medicine more personalized
and precise.
An adverse drug
event (ADE) occurs when a consumer of prescription drugs (Rx)
is harmed by a medicine. Older adults (65 years+) visit emergency
departments almost 450,000 times each year, more than twice as often as younger
persons.
ADEs cause
approximately 1.3 million emergency department visits each year. About 350,000
patients each year need to be hospitalized for further treatment after
emergency visits for ADEs. In 2007, the Institute of Medicine estimated that
approximately 1.5 million preventable ADEs occur each year in the US alone.
In 2007, the Institute of
Medicine estimated that approximately 1.5 million preventable
ADEs occur each year in the US.
As a truly
innovative category creator, the company has been exploring the use of AI and
ML to assist critical care and wellness in managing drug-food and drug-drug
Interactions, preventing adverse drug effects (ADRs) which is seen through
their patent activity on drug-food Interaction management technology. The
company has been appraised at
$150 million for their drug-food technology.
The Epillo
mobile application is currently free for its users but will have a subscription
fee in place in near future. The premium offering will include drug-drug and
drug-food management analysis for patients, connected device monitoring and
wellbeing management features, creating a complete medical, health and wellness
suite supported by 24x7 virtual primary and specialty care assistance as quoted
by Epillo’s CEO Aasif Shah.
Future updates
in Epillo’s innovation basket will witness the complete digital healthcare
solution hosted over a decentralized ledger model. The adoption of the
blockchain distributed ledger model in Epillo’s Digital Health solutions will
create an unprecedented level of accuracy, privacy, and security in health data
for healthcare stakeholders and patients, offering an innovative way to ensure
robust data integrity while giving patients more access and control over their
data in our healthcare applications'' says Dr. Bhupinder Singh (Chair of Board,
Epillo Health Systems).
Comments
Post a Comment